Latest filing published 29 Mar 2025 for Bafna Pharmaceuticals Limited, €244k.
Filing timeline
BuySaleSRJR Lifesciences LLP: trading record in brief
SRJR Lifesciences LLP is a declared insider of Bafna Pharmaceuticals Limited, with filings sourced from SEBI (PIT + SAST). In total, 8 filings cover trades dated from 1 June 2022 to 28 March 2025.
Sales make up the whole of the open-market record (6 sales, €123k).
On 29 March 2025 came the latest disclosure, a transaction for €2.2M in Bafna Pharmaceuticals Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 3 days. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to SRJR Lifesciences LLP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 314,530 shares@ ₹72.009.5% of flowEquity SharesSEBI:ff57d4bbed4f931520044f4bf046e89257fa0195
- 2,830,766 shares@ ₹72.0085.8% of flowEquity SharesSEBI:762be6eb55b98aa2d22dfeada2aecaa16187f3f1
- 8,897 shares@ ₹103.01990.4% of flowEquity SharesSEBI:df736f9e5ca6cc3f0a1deb173f7120f4ec5b978e
- 9,883 shares@ ₹109.67240.5% of flowEquity SharesSEBI:56c8b9659710f0e6e839bf01326478b40ad0cd03
- 27,218 shares@ ₹123.03021.6% of flowEquity SharesSEBI:2487d88c41b09265b162fed6ab2227efa69c125a
- 13,135 shares@ ₹127.000.8% of flowEquity SharesSEBI:20724b518edc8382a271ae5dd3ceb80f8d19da9f
- 11,123 shares@ ₹123.000.6% of flowEquity SharesSEBI:ba398ba46904faae0655c1c6be01bd7378fd1369
- 14,756 shares@ ₹118.61920.8% of flowEquity SharesSEBI:63fc2b856b2449cdb77caf30cfca2a33ff06fd96
8 of 8 declarations